英文名稱 |
中文名稱 |
CAS號 |
操作 |
330191-03-2 |
|
330191-03-2 |
詳細(xì)
|
Apricitabine |
阿立他濱 |
160707-69-7 |
詳細(xì)
|
PCO371 |
PCO371 |
1613373-33-3 |
詳細(xì)
|
2,2'-((ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(6-((2-(2-(2-aminoethoxy)ethoxy)ethyl)amino)-1H-benzo[de]isoquinoline-1,3(2H)-dione) |
|
438200-66-9 |
詳細(xì)
|
BAR501 |
CPDD0945 |
1632118-69-4 |
詳細(xì)
|
1070262-84-8 |
|
1070262-84-8 |
詳細(xì)
|
496018-25-8 |
|
496018-25-8 |
詳細(xì)
|
GSK579289A |
GSK 461364 analogue I |
929095-23-8 |
詳細(xì)
|
VMY-1-103 |
|
1209002-43-6 |
詳細(xì)
|
Leinamycin |
leinamycin |
120500-15-4 |
詳細(xì)
|
ROXNHSester,5-isomer |
5-Carboxy-X-rhodamine N-succinimidyl ester |
344402-35-3 |
詳細(xì)
|
1210138-50-3 |
|
1210138-50-3 |
詳細(xì)
|
522641-12-9 |
|
522641-12-9 |
詳細(xì)
|
Harmine 19a HCL |
|
2699749-60-3 |
詳細(xì)
|
XL-647 |
XL-647 |
651031-01-5 |
詳細(xì)
|
CMX990 |
|
2882934-64-5 |
詳細(xì)
|
INCB0123667 |
|
|
詳細(xì)
|
Compound 6q |
SURELIGHT SULFO-SMCC活化PERCP |
1497439-74-3 |
詳細(xì)
|
3,4-Difluoro-2-methoxyphenylacetic acid |
3,4-二氟-2-甲氧基苯乙酸 |
1558274-26-2 |
詳細(xì)
|
GDC-0334 |
GDC-0334 |
1984824-54-5 |
詳細(xì)
|
1269205-42-6 |
|
1269205-42-6 |
詳細(xì)
|
Perfluoroheptane sulfinate |
甲醇中全氟庚烷亞磺酸鹽 |
769067-51-8 |
詳細(xì)
|
Quinupristin |
奎奴普丁 |
120138-50-3 |
詳細(xì)
|
956288-55-4 |
|
956288-55-4 |
詳細(xì)
|
1381549-67-2 |
|
1381549-67-2 |
詳細(xì)
|
IU1-248 |
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]- |
2307472-03-1 |
詳細(xì)
|
APHIDICOLIN |
艾菲地可寧 |
38966-21-1 |
詳細(xì)
|
TIQ-15 |
TIQ-15 |
1380336-17-3 |
詳細(xì)
|
Formalin;Methanal |
甲醛; 福爾馬林 |
50-00-0 |
詳細(xì)
|
TDI-11055 |
|
2657651-10-8 |
詳細(xì)
|
Feniralstat |
化合物 FENIRALSTAT |
2166320-76-7 |
詳細(xì)
|
Milveterol HCl |
Milveterol hydrochloride |
804518-03-4 |
詳細(xì)
|
E3 Ligase Ligand-linker Conjugate 113 |
|
2378054-01-2 |
詳細(xì)
|
Nelotanserin |
1-[3-(4-溴-1-甲基-1H-吡唑-5-基)-4-甲氧基苯基]-3-(2,4-二氟苯基)脲 |
839713-36-9 |
詳細(xì)
|
MS1943 |
MS1943 |
2225938-17-8 |
詳細(xì)
|
BCN-endo-PEG2-maleimide |
|
2675364-08-4 |
詳細(xì)
|
FAPI |
FAPI |
2471983-20-5 |
詳細(xì)
|
Posiphen |
Posiphen |
116839-68-0 |
詳細(xì)
|
6,8-Difluoro-4-Methyl-uMbelliferyl phosphate |
6,8-二氟-4-甲基傘形酮磷酸酯 |
214491-43-7 |
詳細(xì)
|
Jaktinib Hydrochloride |
鹽酸杰克替尼 |
2056097-81-3 |
詳細(xì)
|
KMI169 |
|
|
詳細(xì)
|
DA-143 |
|
|
詳細(xì)
|
CN128 hydrochloride |
CN128 |
1335282-05-7 |
詳細(xì)
|
YM-254890 |
L-Threonine, N-acetyl-L-threonyl-(αR)-α-hydroxybenzenepropanoyl-2,3-didehydro-N-methylalanyl-L-alanyl-N-methyl-L-alanyl-(3R)-3-[[(2S,3R)-2-(acetylamino)-3-hydroxy-4-methyl-1-oxopentyl]oxy]-L-leucyl-N,O-dimethyl-, (7→1)-lactone |
568580-02-9 |
詳細(xì)
|
TZ3O |
化合物 TZ3O |
2218754-19-7 |
詳細(xì)
|
PA Janelia Fluor 646, SE |
PA JANELIA FLUOR 646, SE |
2093120-32-0 |
詳細(xì)
|
Cicaprost |
Cicaprost |
94079-80-8 |
詳細(xì)
|
MRK 003 |
(3'R,6S,9R)-5,6,7,8,9,10-六氫-5'-(2,2,2-三氟乙基)-2-[(1E)-3-[4-(三氟甲基)-1-哌啶基]-1-丙烯-1-基]螺[6,9-亞甲基苯并環(huán)辛烯E-11,3'-[1,2,5]噻二唑烷] 1',1'-二氧化物 |
623165-93-5 |
詳細(xì)
|
Donidalorsen |
|
2304692-48-4 |
詳細(xì)
|
PROTAC AR Degrader-5 |
|
2703021-51-4 |
詳細(xì)
|
Cantuzumab mertansine |
cantuzumab mertansine |
400010-39-1 |
詳細(xì)
|
ND-336 |
ND-336 |
1807453-83-3 |
詳細(xì)
|
Clezutoclax |
化合物 CLEZUTOCLAX |
1949843-71-3 |
詳細(xì)
|
iptacopan hydrochloride |
伊普可泮 |
2447007-60-3 |
詳細(xì)
|
DGN549-L |
|
1884276-68-9 |
詳細(xì)
|
(S)-(+)-Rolipram |
S- (+)-Rolipram |
85416-73-5 |
詳細(xì)
|
Vaborbactam |
法硼巴坦 |
1360457-46-0 |
詳細(xì)
|
PQCA |
1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid |
1144504-35-7 |
詳細(xì)
|
Elomotecan hydrochloride |
220997-99-9 |
220997-99-9 |
詳細(xì)
|
UU-T02 |
UU-T02; UU-T-02; UU-T 02; UUT02; UUT-02; UUT 02 |
1500080-17-0 |
詳細(xì)
|
Antitumor agent-67 |
化合物 ANTITUMOR AGENT-67 |
2820146-10-7 |
詳細(xì)
|
Y 33075 |
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺 |
199433-58-4 |
詳細(xì)
|
KTX-951 |
6-(1,1-二氟乙基)-N-(2-(反式-4-((2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氨基)乙基)-7-氮雜螺[3.5]壬烷-7-基)甲基)環(huán)己基)-6-甲氧基-2H-吲唑-5-基)吡啶-2-甲酰胺 |
2573298-36-7 |
詳細(xì)
|
GSK620 |
GSK620 |
2088410-46-0 |
詳細(xì)
|
Mardepodect hydrochloride |
MARDEPODECT HYDROCHLORIDE |
2070014-78-5 |
詳細(xì)
|
2857047-24-4 |
|
2857047-24-4 |
詳細(xì)
|
Androgenreceptorantagonist1 |
Androgen receptor antagonist 1 |
1338812-36-4 |
詳細(xì)
|
TMX1 |
枸櫞酸他莫昔芬 |
54965-24-1 |
詳細(xì)
|
GSPT1 degrader-1 |
|
3037491-05-4 |
詳細(xì)
|
PF-07328948 |
|
2936625-34-0 |
詳細(xì)
|
PLX-4545 |
PLX 4545 ; PLX4545 |
2892065-45-9 |
詳細(xì)
|
EOS-984 |
|
2724937-55-5 |
詳細(xì)
|
MMH2 |
|
|
詳細(xì)
|
BMS-986408 |
|
2618418-12-3 |
詳細(xì)
|
Juncosamine (DMBMPP) |
化合物 5-HT2A RECEPTOR AGONIST-3 |
1391499-52-7 |
詳細(xì)
|
ZY-19489 |
化合物T67694 |
1821293-40-6 |
詳細(xì)
|
Setidegrasib/KRAS G12D inhibitor 17 |
|
2821793-99-9 |
詳細(xì)
|
NS 383 |
NS 383 |
309711-59-9 |
詳細(xì)
|
1-Heptanesulfinic Acid Sodium Salt |
sodium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptane-1-sulphinate |
68555-66-8 |
詳細(xì)
|
902871-73-2 |
|
902871-73-2 |
詳細(xì)
|
MMH1 |
|
|
詳細(xì)
|
Cyanine5 DSPE |
CY5 DSPE |
2260669-68-7 |
詳細(xì)
|
Cpd.37 |
|
|
詳細(xì)
|
1-Hydroxy-7-methoxy-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid |
|
2085239-40-1 |
詳細(xì)
|
873675-48-0 |
|
873675-48-0 |
詳細(xì)
|
BD 1008 Free Base |
化合物 BD 1008 FREE BASE |
138356-08-8 |
詳細(xì)
|
IDO1/TDO-IN-1 |
化合物 IDO1/TDO-IN-1 |
2379527-72-5 |
詳細(xì)
|
BMS-986224 |
BMS-986224 |
2055200-88-7 |
詳細(xì)
|
dE-DHP |
|
130816-05-6 |
詳細(xì)
|
2173562-79-1 |
|
2173562-79-1 |
詳細(xì)
|
CM398 |
化合物 CM398 |
1121931-70-1 |
詳細(xì)
|
Zamzetoclax |
|
2388470-64-0 |
詳細(xì)
|
TAK-861 |
|
|
詳細(xì)
|
CQ80 |
|
3034207-17-2 |
詳細(xì)
|
methyl 4-((2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxamido)picolinate |
4-(2R,3S,4S,5R)-3-(3,4-二氟-2-甲氧基苯基)-4,5-二甲基-5-三氟甲基四氫呋喃-2-甲酰胺基吡啶甲酸甲酯 |
2879218-02-5 |
詳細(xì)
|
TREX1-IN-1 |
化合物 TREX1-IN-1 |
2756594-27-9 |
詳細(xì)
|
(2S,4R)-1-((R)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride |
|
2761478-98-0 |
詳細(xì)
|
BI-9787 |
|
3043939-18-7 |
詳細(xì)
|
AZD4144 |
AZD4144 |
2890191-41-8 |
詳細(xì)
|
LysoPC(20:3(5Z,8Z,11Z)) |
|
1199257-41-4 |
詳細(xì)
|